Latest news

Every donation will support a kidney cancer patient in Canada.

New Research Chair in Kidney Cancer in Atlantic Canada

Sunitinib rechallenge benefited select metastatic renal cell carcinomas

U.S. FDA approves GSK’s Votrient (pazopanib) for mrcc

Bayer’s Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients

Rises in incidence of kidney cancer

Rises in incidence of kidney cancer

Axitinib showing promise for rcc

Pazopanib shows positive results in phase II trials

Avastin approved in EU for rcc

ABT-869 Trial for Advanced RCC

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.

This site is registered on Toolset.com as a development site.